View in EDS HTML Full Text

Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution Experience.

Saved in:
Bibliographic Details
Title: Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution Experience.
Authors: Elghawy O; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA., Wang J; Department of Pathology and Laboratory Medicine, Division of Hematopathology, Hospital of the University of Pennsylvania, Philadelphia, PA., Leung OJ; Department of Pathology and Laboratory Medicine, Division of Hematopathology, Hospital of the University of Pennsylvania, Philadelphia, PA., Swami N; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA., Carvajal V; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA., Yang G; Division of Precision and Computational Diagnostics, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA., Landsburg DJ; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Svoboda J; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Nasta SD; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Chong EA; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Schuster SJ; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Thomas CJ; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Carter JS; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Bagg A; Department of Pathology and Laboratory Medicine, Division of Hematopathology, Hospital of the University of Pennsylvania, Philadelphia, PA., Barta SK; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. Electronic address: Stefan.Barta@pennmedicine.upenn.edu.
Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2025 Jul; Vol. 25 (7), pp. 505-511.e2. Date of Electronic Publication: 2025 Feb 03.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39984393
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution Experience.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Elghawy+O%22">Elghawy O</searchLink>; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Department of Pathology and Laboratory Medicine, Division of Hematopathology, Hospital of the University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Leung+OJ%22">Leung OJ</searchLink>; Department of Pathology and Laboratory Medicine, Division of Hematopathology, Hospital of the University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Swami+N%22">Swami N</searchLink>; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Carvajal+V%22">Carvajal V</searchLink>; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Yang+G%22">Yang G</searchLink>; Division of Precision and Computational Diagnostics, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Landsburg+DJ%22">Landsburg DJ</searchLink>; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Svoboda+J%22">Svoboda J</searchLink>; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Nasta+SD%22">Nasta SD</searchLink>; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Chong+EA%22">Chong EA</searchLink>; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Schuster+SJ%22">Schuster SJ</searchLink>; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Thomas+CJ%22">Thomas CJ</searchLink>; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Carter+JS%22">Carter JS</searchLink>; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Bagg+A%22">Bagg A</searchLink>; Department of Pathology and Laboratory Medicine, Division of Hematopathology, Hospital of the University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Barta+SK%22">Barta SK</searchLink>; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. Electronic address: Stefan.Barta@pennmedicine.upenn.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2025 Jul; Vol. 25 (7), pp. 505-511.e2. <i>Date of Electronic Publication: </i>2025 Feb 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39984393
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clml.2025.01.017
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 505
    Titles:
      – TitleFull: Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution Experience.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Elghawy O
      – PersonEntity:
          Name:
            NameFull: Wang J
      – PersonEntity:
          Name:
            NameFull: Leung OJ
      – PersonEntity:
          Name:
            NameFull: Swami N
      – PersonEntity:
          Name:
            NameFull: Carvajal V
      – PersonEntity:
          Name:
            NameFull: Yang G
      – PersonEntity:
          Name:
            NameFull: Landsburg DJ
      – PersonEntity:
          Name:
            NameFull: Svoboda J
      – PersonEntity:
          Name:
            NameFull: Nasta SD
      – PersonEntity:
          Name:
            NameFull: Chong EA
      – PersonEntity:
          Name:
            NameFull: Schuster SJ
      – PersonEntity:
          Name:
            NameFull: Thomas CJ
      – PersonEntity:
          Name:
            NameFull: Carter JS
      – PersonEntity:
          Name:
            NameFull: Bagg A
      – PersonEntity:
          Name:
            NameFull: Barta SK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2152-2669
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Clinical lymphoma, myeloma & leukemia
              Type: main
ResultId 1